PATENT CLAIM ANALYSIS

Application Number: 16206448
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "186100"]

Abstract:
The present invention provides recombinant adenoviral compositions and methods for their use in treating disorders associated with epithelial tissues.

Claim (Index 11):
The recombinant AdB-2/3 fiber polypeptide of  claim 7 , wherein each shaft domain is selected from the group consisting of an Ad3 fiber polypeptide shaft domain, an Ad7 fiber polypeptide shaft domain, an Ad11 fiber polypeptide shaft domain, an Ad 14 fiber polypeptide shaft domain, an Ad14a fiber polypeptide shaft domain, combinations thereof, and functional equivalents thereof.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 98.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15593578', '14429803', '13158246', '14066353', '15538975']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8128275521751218
- 35 USC 102 Novelty (BERT): 0.7164508022787826
- Combined Prediction Score: 0.803189877185488
- Mean Citation Score: 620.776718
- Max Citation Score: 795.7945599999997
- Similarity Product: 751.9909902147673

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test